These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3059189)

  • 1. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril.
    Rett K; Wicklmayr M; Dietze GJ
    N Engl J Med; 1988 Dec; 319(24):1609. PubMed ID: 3059189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects and interactions of oral antidiabetics].
    Czyzyk A; Stryjek-Kamińska D
    Pol Tyg Lek; 1980 Nov; 35(45):1757-60. PubMed ID: 7012809
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral antidiabetics].
    Bäbler M
    Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral hypoglycemic agents.
    Forbath N
    Prim Care; 1977 Dec; 4(4):629-36. PubMed ID: 337336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complications in the therapy of diabetes using oral hypoglycemic agents].
    De Luca E; Pellegrini M
    Minerva Med; 1974 Dec; 65(90):4769-71. PubMed ID: 4449610
    [No Abstract]   [Full Text] [Related]  

  • 9. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined administration of oral agents in insulin therapy].
    Oneta A
    Nihon Rinsho; 1973 Jul; 31(7):2293-7. PubMed ID: 4795330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined administration of insulin and oral agents].
    Tasaka H
    Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
    Holstein A; Hahn M; Stumvoll M; Kovacs P
    Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoglycemia in diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1992; 19(4):100-5. PubMed ID: 1290316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E; Monami M; Masotti G; Marchionni N
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The risk of hypoglycemia in sulfonylurea therapy].
    Berger W; Koller F
    Helv Med Acta; 1972 Apr; 36(2):228-9. PubMed ID: 5029101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.